Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum toxin for management of Popeye sign after biceps tenotomy
2020-005547-23Phase 4Completed
- Sponsor
- AZ Delta
- Start
- Apr 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of botulinum toxin type A in Long head of the biceps tendon rupture (LHBTR) and Musculoskeletal pain (2 arms), sponsored by AZ Delta. Primary endpoint: Pain reduction (VAS). Started Apr 2021; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
Long head of the biceps tendon rupture (LHBTR)Musculoskeletal pain
Beyond the preview
Go deeper on 2020-005547-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-005547-23.